Product Information
ZITHROMAX 250 MG TABLET is a brand product labeled by Pfizer Inc., priced at $2.0670 per EA under NDC 00069406101. Its NADAC has been published 171 times since Feb 23, 2022.
The High Outlier badge above means this manufacturer's average price in the azithromycin dihydrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
250 mg/1
Manufacturer
Pfizer Inc.NDC
00069406101
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
8/20/2025
Active Ingredients
AZITHROMYCIN DIHYDRATEApproval Type
New Drug (NDA)
FDA Application
NDA050711On Market Since
5/17/2019
Pharmacological Classes
Price Statistics
The NADAC for ZITHROMAX 250 MG TABLET has been published 171 times since Feb 23, 2022, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0670 per EA |
|---|---|
| All-time high | $2.0827 (Sep 11, 2024) |
| All-time low | $2.0670 (Jul 23, 2025) |
| 52-week high | $2.0804 |
| 52-week low | $2.0670 |
| Median price | $2.0795 |
| Average price | $2.0762 |
| Largest weekly change | -0.6% (Jul 23, 2025) |
| Weeks tracked | 171 |
| Tracking since | Feb 23, 2022 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ZITHROMAX 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZITHROMAX 250 MG TABLET, manufactured by Pfizer Inc., is $2.0670 per EA (NDC 00069406101), effective Jun 24, 2026.
How has the price of ZITHROMAX 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZITHROMAX 250 MG TABLET has held within roughly two percent of its current level. It has been tracked across 171 weekly CMS publications since Feb 23, 2022.
What are the highest and lowest recorded NADAC prices for ZITHROMAX 250 MG TABLET?
Since Feb 23, 2022, the NADAC for ZITHROMAX 250 MG TABLET has ranged from a low of $2.0670 (Jul 23, 2025) to a high of $2.0827 (Sep 11, 2024), with a median of $2.0795 per EA.
Are there cheaper alternatives to ZITHROMAX 250 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as ZITHROMAX 250 MG TABLET, but none are currently priced below it.
Who manufactures ZITHROMAX 250 MG TABLET?
ZITHROMAX 250 MG TABLET (NDC 00069406101) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification